Reaction to Justin Trudeau’s win has been coming in throughout the day.

B.C. Premier Christy Clark spoke to the media Tuesday afternoon, thanking Stephen Harper and all the outgoing MPs for their service.

She also congratulated Trudeau on his victory, expressing confidence he will be open to working closely with the B.C. government.

Touching on a number of points including the legalization of marijuana, Clark said “it’s a federal issue and we will work with the government in whatever moves they make on this front.”

One of the incoming Liberal government’s more high-profile campaign planks is its plan to legalize recreational marijuana use, which raises the spectre that Vancouver’s ubiquitous – and, at least for now, illegal – pot shops could soon bloom across the country.

But long-time MP and recent Liberal health critic Hedy Fry said any move to allow storefront sales of cannabis – whether at retail shops or pharmacies, or both – would need approval from an upcoming task force comprising municipal, provincial and federal politicians, law enforcement, and public health and addiction experts.

Alison Ettel can attest to the healing powers of cannabis. You’d never know it by sight, but the bright, bubbly young woman behind TreatWell had a near-death experience a few years ago. While she had never tried cannabis prior and hasn’t since, using marijuana as a medicine during her recovery changed her life.

There is plenty of anecdotal evidence that people suffering from pain, nausea, anxiety or other forms of emotional distress often swap their prescription drugs for marijuana when they can.

A new study completed by the Centre for Addictions Research of British Columbia and published in the journal Drug and Alcohol Review adds yet more scientific rigor to the casual observations. The reported results are also consistent with previous studies going back several years.

The Canadian Medical Association and the federal government apply a far more rigid standard to prescribing marijuana, resulting in negative — or even deadly consequences, say experts from the B.C. Centre for Excellence in HIV/AIDS.

Medical marijuana is held to a different standard than other prescription drugs despite research suggesting it has therapeutic benefits, say three experts from the centre in a commentary publish Friday in the Journal of the Canadian Public Health Association.

“When it comes to prescription marijuana, patients’ needs should be considered above political considerations,” Dr. Julio Montaner, one of the authors, said in a news release. “There could be great harm in ignoring the medical uses of marijuana.”

VANCOUVER – Two local leaders in HIV/AIDS research are breaking ranks from their medical association, calling for it to change its approach to medical marijuana.

The rules don’t rely on the most up-to-date science, according to Doctors Thomas Kerr and Julio Montaner with the BC Centre for Excellence in HIV/AIDS.

They argue pot can be just as effective in treating pain as other drugs, but it’s being held to a higher standard by the Canadian Medical Association.

Medical marijuana could cut down on the use of addictive painkillers according to a new paper in the Canadian Journal of Public Health, but some of Vancouver's best known researchers say reluctant doctors and a confused federal government are failing to act.

 "When it comes to prescription marijuana, patients' needs should be considered above political considerations," said study co-author Dr. Julio Montaner of the B.C. Centre for Excellence in HIV/AIDS. "There could be great harm in ignoring the medical uses of marijuana."

Study co-author Dr. Thomas Kerr says Canada is in the midst of an epidemic of opioid abuse and related overdose deaths, and that numerous studies have shown painkillers such as oxycontin are dangerous and prescribed too frequently.

Canadian doctors should use medical marijuana instead of frequently abused opioids to treat patients with neuropathic pain and a host of other conditions cannabis has been proven to combat, Vancouver-based HIV/AIDS researchers argue in a newly published editorial.

Thomas Kerr, Julio Montaner and Stephanie Lake of the B.C. Centre for Excellence in HIV/AIDS argue the Canadian Medical Association is holding pot to a higher standard than other pain-relieving pharmaceutical drugs and is ignoring high-quality, peer-reviewed studies on the use of cannabis. Their editorial is in the latest edition of the Journal of the Canadian Public Health Association.

KELOWNA, BC / ACCESSWIRE / October 8, 2015 / Lexaria Corp. (LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce that the manufacturing process to infuse active hemp oil utilizing Lexaria's patent pending technology designed to provide higher bioavailability, has been completed for both coffee and hot chocolate. Both products are currently under packaging development and will be available for our customers soon.

VANCOUVER - The Canadian Medical Association and the federal government apply a far more rigid standard to prescribing marijuana than other drugs, resulting in negative - or even deadly - consequences, say experts from the B.C. Centre for Excellent in HIV/AIDS.

Medical marijuana is held to a different standard than other prescription drugs despite research suggesting it has therapeutic benefits, say three experts from the centre in a commentary published Friday in the Journal of the Canadian Public Health Association.

"When it comes to prescription marijuana, patients' needs should be considered above political considerations," Dr. Julio Montaner, one of the authors, said in a news release. "There could be great harm in ignoring the medical uses of marijuana."